Horizon Investments LLC Has $1.45 Million Position in Axon Enterprise, Inc $AXON

Horizon Investments LLC cut its holdings in Axon Enterprise, Inc (NASDAQ:AXON) by 48.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 2,544 shares of the biotechnology company’s stock after selling 2,425 shares during the quarter. Horizon Investments LLC’s holdings in Axon Enterprise were worth $1,445,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of AXON. Stone House Investment Management LLC bought a new stake in shares of Axon Enterprise during the 3rd quarter valued at $29,000. New Millennium Group LLC acquired a new stake in shares of Axon Enterprise during the third quarter worth $29,000. Sound Income Strategies LLC grew its stake in shares of Axon Enterprise by 550.0% during the fourth quarter. Sound Income Strategies LLC now owns 52 shares of the biotechnology company’s stock worth $30,000 after purchasing an additional 44 shares during the period. Camelot Portfolios LLC bought a new stake in Axon Enterprise in the fourth quarter valued at about $30,000. Finally, Root Financial Partners LLC acquired a new position in Axon Enterprise in the third quarter valued at about $34,000. Institutional investors and hedge funds own 79.08% of the company’s stock.

Insiders Place Their Bets

In related news, CEO Patrick W. Smith sold 10,000 shares of the company’s stock in a transaction on Wednesday, February 25th. The shares were sold at an average price of $500.24, for a total value of $5,002,400.00. Following the completion of the transaction, the chief executive officer directly owned 3,090,997 shares of the company’s stock, valued at approximately $1,546,240,339.28. This represents a 0.32% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Jeri Williams sold 157 shares of the stock in a transaction dated Tuesday, March 17th. The stock was sold at an average price of $490.00, for a total value of $76,930.00. Following the transaction, the director owned 1,159 shares of the company’s stock, valued at approximately $567,910. This trade represents a 11.93% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 13,855 shares of company stock worth $7,109,828 in the last ninety days. 4.40% of the stock is owned by insiders.

Axon Enterprise Trading Up 1.4%

NASDAQ:AXON opened at $385.86 on Thursday. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.53 and a quick ratio of 2.29. The stock has a market capitalization of $31.09 billion, a PE ratio of 253.86, a price-to-earnings-growth ratio of 8.12 and a beta of 1.44. The business’s 50-day simple moving average is $452.24 and its 200-day simple moving average is $529.24. Axon Enterprise, Inc has a fifty-two week low of $339.01 and a fifty-two week high of $885.91.

Axon Enterprise (NASDAQ:AXON) last announced its quarterly earnings results on Tuesday, February 24th. The biotechnology company reported $2.15 earnings per share for the quarter, beating analysts’ consensus estimates of $1.60 by $0.55. The firm had revenue of $796.72 million for the quarter, compared to analyst estimates of $755.29 million. Axon Enterprise had a net margin of 4.48% and a return on equity of 2.82%. The business’s revenue was up 38.5% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.08 earnings per share. Sell-side analysts expect that Axon Enterprise, Inc will post 1.41 earnings per share for the current fiscal year.

Key Axon Enterprise News

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Q1 revenue of ~$807M, up ~34% year‑over‑year; software & services grew ~35% and AI/counter‑drone products posted very large percentage gains — clear top‑line momentum that beat consensus. PR Newswire Release
• Positive Sentiment: Company raised its full‑year revenue growth outlook (to roughly 30–32% growth) and reiterated a strong Adjusted EBITDA margin target and free cash flow expectations — a constructive guidance update. Reuters: Raises Forecast
• Positive Sentiment: Non‑GAAP EPS of $1.61 was roughly in line with/just above some consensus models and revenue beat consensus by a solid margin — supports the narrative of profitable growth. Yahoo Finance: Q1 Results
• Neutral Sentiment: Analysts and previews had already priced in strong TASER, body‑camera and software demand; some brokerage notes suggested Axon could raise the low end of FY guidance even before the print (a pre‑earnings positioning effect). Yahoo Preview
• Neutral Sentiment: Company released supplemental materials (press release, slide deck and call transcript) — useful for digging into product KPIs and margin drivers but neutral until new customer/contract details emerge. MarketBeat: Materials
• Negative Sentiment: Some outlets and models flagged an EPS shortfall versus certain estimates (Zacks noted a miss vs its $1.66 consensus), creating confusion about the quality of the beat. Zacks: EPS vs Estimates
• Negative Sentiment: Despite the top‑line beat and raised guide, some trading sessions showed the stock slipping — investors remain concerned about high valuation, margin sustainability and a large YTD share price decline that reduces upside from good prints. Yahoo: Valuation/Performance
• Negative Sentiment: Intraday headlines noted shares “slip” in some sessions despite results, highlighting the mixed market reception and that execution vs. model expectations still matters to investor sentiment. Benzinga: Market Reaction

Analyst Ratings Changes

AXON has been the topic of a number of recent analyst reports. Piper Sandler reduced their target price on Axon Enterprise from $753.00 to $690.00 and set an “overweight” rating on the stock in a report on Wednesday, February 25th. UBS Group lowered their price target on Axon Enterprise from $610.00 to $570.00 and set a “neutral” rating for the company in a research note on Wednesday, February 25th. Royal Bank Of Canada cut their price target on shares of Axon Enterprise from $860.00 to $735.00 and set an “outperform” rating on the stock in a research report on Wednesday, February 25th. Needham & Company LLC decreased their price objective on shares of Axon Enterprise from $870.00 to $600.00 and set a “buy” rating for the company in a report on Friday, February 20th. Finally, Weiss Ratings downgraded shares of Axon Enterprise from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Friday, April 10th. Sixteen analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, Axon Enterprise currently has a consensus rating of “Moderate Buy” and an average target price of $749.63.

Axon Enterprise Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.